A Mouse Model of Cavernous Nerve Injury-Induced Erectile Dysfunction: Functional and Morphological Characterization of the Corpus Cavernosum

被引:51
作者
Jin, Hai-Rong [1 ,2 ]
Chung, Yeun Goo [1 ,2 ]
Kim, Woo Jean [1 ,2 ]
Zhang, Lu Wei [1 ,2 ]
Piao, Shuguang [1 ,2 ]
Tuvshintur, Buyankhuu [1 ,2 ]
Yin, Guo Nan [1 ,2 ]
Shin, Sun Hwa [1 ,2 ]
Tumurbaatar, Munkhbayar [1 ,2 ]
Han, Jee-Young [3 ]
Ryu, Ji-Kan [1 ,2 ]
Suh, Jun-Kyu [1 ,2 ]
机构
[1] Inha Univ, Sch Med, Natl Res Lab Regenerat Sexual Med, Inchon 400711, South Korea
[2] Inha Univ, Sch Med, Dept Urol, Inchon 400711, South Korea
[3] Inha Univ, Sch Med, Dept Pathol, Inchon 400711, South Korea
关键词
Radical Prostatectomy; Erectile Dysfunction; Animal Model; Mouse; SMOOTH-MUSCLE; TRANSFORMING GROWTH-FACTOR-BETA-1; ENDOTHELIAL-CELLS; FUNCTION RECOVERY; CRUSH INJURY; RAT MODEL; GROWTH; PROLIFERATION; PROSTATECTOMY; NEUROTOMY;
D O I
10.1111/j.1743-6109.2010.01942.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. With the advent of genetically engineered mice, it seems important to develop a mouse model of cavernous nerve injury (CNI). Aim. To establish a mouse model of CNI induced either by nerve crushing or by neurectomy and to evaluate time-dependent derangements in penile hemodynamics in vivo and subsequent histologic alterations in the cavernous tissue. Methods. Twelve-week-old C57BL/6J mice were divided into 4 groups (N = 36 per group): control, sham operation, bilateral cavernous nerve crush, and bilateral cavernous neurectomy group. Main Outcome Measures. Three days and 1, 2, 4, 8, and 12 weeks after CNI, erectile function was measured by electrical stimulation of the cavernous nerve. The penis was then harvested and TUNEL was performed. Immunohistochemical analysis was performed assaying for caspase-3, transforming growth factor-beta 1 (TGF-beta 1), phospho-Smad2, PECAM-1, factor VIII, and smooth muscle alpha-actin. The numbers of apoptotic cells and phospho-Smad2-immunopositive cells in endothelial cells or smooth muscle cells were counted. Results. Erectile function was significantly less in the cavernous nerve crushing and neurectomy groups than in the control or sham group. This difference was observed at the earliest time point assayed (day 3) and persisted up to 4 weeks after nerve crushing and to 12 weeks after neurectomy. The apoptotic index peaked at 1 or 2 weeks after CNI and decreased thereafter. Cavernous TGF-beta 1 and phospho-Smad expression was also increased after CNI. The numbers of apoptotic cells and phospho-Smad2-immunopositive cells in cavernous endothelial cells and smooth muscle cells were significantly greater in the cavernous nerve crush and cavernous neurectomy groups than in the control or sham group. Conclusion. The mouse is a useful model for studying pathophysiologic mechanisms involved in erectile dysfunction after CNI. Early intervention to prevent apoptosis in smooth muscle cells and endothelial cells or to inhibit cavernous tissue fibrosis is required to restore erectile function. Jin H-R, Chung YG, Kim WJ, Zhang LW, Piao S, Tuvshintur B, Yin GN, Shin SH, Tumurbaatar M, Han J-Y, Ryu J-K, and Suh J-K. A mouse model of cavernous nerve injury-induced erectile dysfunction: Functional and morphological characterization of the corpus cavernosum. J Sex Med 2010;7:3351-3364.
引用
收藏
页码:3351 / 3364
页数:14
相关论文
共 50 条
  • [31] Application of hNGFβ-Modified Adipose-Derived Stem Cells in Treating Cavernous Nerve Injury-Induced Erectile Dysfunction in Rat Models
    Qi, Tao
    Chen, Jun
    Ye, Lei
    Wang, Bo
    Huang, Zhansen
    Li, Hao
    Dou, Zulin
    Zhang, Bin
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2017, 7 (11) : 1093 - 1101
  • [32] A novel flavonoid derivative of icariside II improves erectile dysfunction in a rat model of cavernous nerve injury
    Gu, Sheng-Ji
    Li, Meng
    Yuan, Yi-Ming
    Xin, Zhong-Cheng
    Guan, Rui-Li
    ANDROLOGY, 2021, 9 (06) : 1893 - 1901
  • [33] Low-intensity pulsed ultrasound ameliorates erectile dysfunction induced by bilateral cavernous nerve injury through enhancing Schwann cell-mediated cavernous nerve regeneration
    Li, Zitaiyu
    Ye, Kun
    Yin, Yinghao
    Zhou, Jun
    Li, Dongjie
    Gan, Yu
    Peng, Dongyi
    Zhao, Liangyu
    Xiao, Ming
    Zhou, Yihong
    Dai, Yingbo
    Tang, Yuxin
    ANDROLOGY, 2023, 11 (06) : 1188 - 1202
  • [34] Adipose Tissue-Derived Stem Cell Therapy for Cavernous Nerve Injury-Induced Erectile Dysfunction in the Rat Model: A Systematic Review and Meta-Analysis Using Methodological Quality Assessment
    Park, Hyo Jung
    Jeong, Hyunsuk
    Park, Yong Hyun
    Yim, Hyeon Woo
    Ha, U-syn
    Hong, Sung-Hoo
    Kim, Sae Woong
    Kim, Na Jin
    Lee, Ji Youl
    INTERNATIONAL JOURNAL OF STEM CELLS, 2019, 12 (02) : 206 - 217
  • [35] Rat model of erectile dysfunction caused by cavernous nerve ablation
    Zhang, XH
    Hu, LQ
    Yin, J
    Mo, ZN
    Chen, J
    CHINESE MEDICAL JOURNAL, 2002, 115 (08) : 1179 - 1182
  • [36] A potential treatment of low intensity pulsed ultrasound on cavernous nerve injury for erectile dysfunction
    Chiang, Pai-Kai
    Yang, Feng-Yi
    MEDICAL HYPOTHESES, 2019, 122 : 19 - 21
  • [37] Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury
    Bella, Anthony J.
    Lin, Guiting
    Cagiannos, Ilias
    Lue, Tom F.
    ASIAN JOURNAL OF ANDROLOGY, 2008, 10 (01) : 54 - 59
  • [38] Restoring erectile function by combined treatment with JNK inhibitor and HDAC inhibitor in a rat model of cavernous nerve injury
    Lee, Junghoon
    Cho, Min Chul
    Son, Hwancheol
    Kim, Soo Woong
    ANDROLOGY, 2022, 10 (04) : 758 - 766
  • [39] An animal model induced by bilateral cavernous nerve crushing mimics post-radical prostatectomy erectile dysfunction in old rats
    Ge, Yunlong
    Hu, Daoyuan
    Xi, Yuhang
    Wang, Hua
    Xia, Tian
    Chen, Jialiang
    Pu, Xiaoyong
    Xiao, Hengjun
    LIFE SCIENCES, 2023, 325
  • [40] Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury
    Kato, R.
    Wolfe, D.
    Coyle, C. H.
    Wechuck, J. B.
    Tyagi, P.
    Tsukamoto, T.
    Nelson, J. B.
    Glorioso, J. C.
    Chancellor, M. B.
    Yoshimura, N.
    GENE THERAPY, 2009, 16 (01) : 26 - 33